Because of its metabolic role, NNMT is expressed in liver, adipose tissue, kidney, and other tissues
25 Gulcan, E., Toker, S., Hatipolu, H., Gulcan, A
FDA Safety Concerns The FDAs current compounding information states that BPC-157 may present immunogenicity risks for certain routes and raises challenges involving peptide impurities and active-ingredient characterisation
A randomized, double-blind, placebo-controlled trial in 191 older adults (75 years) with moderate vitamin B 12 deficiency (serum cobalamin concentrations of 107-210 pmol/L) without anemia provided participants with 1 mg/day of cyanocobalamin for one year (94)
These effects should subside quickly when you reduce the dosage, but if they persist, please consult your doctor immediately
Anyone considering peptide research should work within their applicable regulations and seek qualified medical guidance